No molecular pharmacological target

The term "No molecular pharmacological target" is a placeholder used in pharmacological databases like ChEMBL to identify drugs that lack a specific protein or nucleic acid target (ChEMBL, 2024). These agents often exert their effects through non-specific chemical or physical mechanisms, such as the neutralization of gastric acid by antacids or the osmotic effects of certain laxatives (PubChem, 2023). This category also encompasses older medications where the precise molecular mechanism remains uncharacterized despite established clinical utility (DrugBank, 2024). For biotech analysts, this designation indicates that the therapeutic profile is not defined by traditional ligand-receptor kinetics or high-affinity binding. Instead, safety and efficacy are often governed by the bulk physical properties of the substance within a physiological compartment. Understanding this classification is essential for distinguishing between targeted precision medicines and broad-acting physiological modifiers. It highlights a unique class of therapeutics where structure-activity relationships are based on physicochemical properties rather than molecular docking. This category is also relevant for regulatory assessments, as the lack of a specific target can complicate the prediction of off-target toxicities.

Other names

Unknown targetNon-specific mechanism of actionTarget not definedNon-molecular target

Therapeutic effect is achieved through non-specific physical or chemical interactions rather than binding to a specific protein, enzyme, or receptor.